| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 101.450 | 98.722 | 139.617 | 139.617 | 157.817 | 205.676 | 188.068 | 331.051 | 282.178 | 263.764 |
| Total Income - EUR | 101.747 | 98.736 | 139.840 | 140.505 | 158.812 | 217.188 | 190.979 | 338.191 | 291.811 | 278.195 |
| Total Expenses - EUR | 89.787 | 95.215 | 133.222 | 138.629 | 149.447 | 162.660 | 144.122 | 253.231 | 271.984 | 204.947 |
| Gross Profit/Loss - EUR | 11.960 | 3.521 | 6.618 | 1.876 | 9.364 | 54.528 | 46.857 | 84.960 | 19.827 | 73.247 |
| Net Profit/Loss - EUR | 9.792 | 2.533 | 5.220 | 471 | 7.776 | 52.633 | 45.198 | 82.282 | 17.405 | 65.567 |
| Employees | 3 | 4 | 4 | 5 | 5 | 5 | 5 | 6 | 5 | 5 |
Check the financial reports for the company - Pharmalog Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 7.368 | 4.999 | 6.441 | 7.307 | 7.026 | 17.826 | 91.853 | 135.123 | 105.015 | 70.409 |
| Current Assets | 38.597 | 16.477 | 24.488 | 19.733 | 28.809 | 51.025 | 55.896 | 88.548 | 53.237 | 59.103 |
| Inventories | 257 | 255 | 250 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 5.765 | 10.251 | 15.736 | 7.927 | 12.581 | 5.614 | 3.850 | 3.269 | 12.016 | 3.818 |
| Cash | 32.575 | 5.971 | 8.503 | 11.807 | 16.228 | 45.411 | 52.046 | 85.279 | 41.221 | 55.285 |
| Shareholders Funds | 30.004 | 18.119 | 23.032 | 23.081 | 30.411 | 61.994 | 79.810 | 162.340 | 107.487 | 100.759 |
| Social Capital | 8.031 | 7.950 | 7.815 | 7.672 | 7.523 | 8.269 | 8.086 | 8.111 | 8.087 | 8.041 |
| Debts | 16.029 | 3.570 | 8.095 | 4.053 | 5.442 | 6.857 | 52.097 | 42.276 | 39.003 | 23.607 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 17.436 | 20.911 | 14.025 | 7.162 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5829 - 5829" | |||||||||
| CAEN Financial Year |
5829
|
|||||||||
Comments - Pharmalog Srl